These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 3113982

  • 1. Dopamine D-2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpiride.
    Filloux FM, Wamsley JK, Dawson TM.
    Eur J Pharmacol; 1987 Jun 12; 138(1):61-8. PubMed ID: 3113982
    [Abstract] [Full Text] [Related]

  • 2. Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase.
    Filloux F, Dawson TM, Wamsley JK.
    Brain Res Bull; 1988 Apr 12; 20(4):447-59. PubMed ID: 3135077
    [Abstract] [Full Text] [Related]

  • 3. Presynaptic and postsynaptic D1 dopamine receptors in the nigrostriatal system of the rat brain: a quantitative autoradiographic study using the selective D1 antagonist [3H]SCH 23390.
    Filloux FM, Wamsley JK, Dawson TM.
    Brain Res; 1987 Apr 07; 408(1-2):205-9. PubMed ID: 2954613
    [Abstract] [Full Text] [Related]

  • 4. 6-Hydroxydopamine lesions reduce specific [3H]sulpiride binding in the rat substantia nigra: direct evidence for the existence of nigral D-2 autoreceptors.
    Morelli M, Carboni E, Devoto S, Di Chiara G.
    Eur J Pharmacol; 1987 Aug 04; 140(1):99-104. PubMed ID: 3113987
    [Abstract] [Full Text] [Related]

  • 5. Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons.
    Beckstead RM.
    Neuroscience; 1988 Dec 04; 27(3):851-63. PubMed ID: 3150855
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM, Dawson VL, Gage FH, Fisher LJ, Hunt MA, Wamsley JK.
    Brain Res; 1991 Feb 01; 540(1-2):145-52. PubMed ID: 1905173
    [Abstract] [Full Text] [Related]

  • 7. Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat.
    Floran B, Aceves J, Sierra A, Martinez-Fong D.
    Neurosci Lett; 1990 Aug 14; 116(1-2):136-40. PubMed ID: 2147981
    [Abstract] [Full Text] [Related]

  • 8. Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat.
    Savasta M, Dubois A, Benavides J, Scatton B.
    Neurosci Lett; 1986 Dec 23; 72(3):265-71. PubMed ID: 2950341
    [Abstract] [Full Text] [Related]

  • 9. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.
    Herkenham M, Lynn AB, de Costa BR, Richfield EK.
    Brain Res; 1991 May 03; 547(2):267-74. PubMed ID: 1909204
    [Abstract] [Full Text] [Related]

  • 10. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C, Slevin JT.
    Synapse; 1989 May 03; 4(3):248-53. PubMed ID: 2532792
    [Abstract] [Full Text] [Related]

  • 11. Binding experiments of muscarinic acetylcholine and dopamine receptors in human brains with emphasis on a case of striatonigral degeneration.
    Shimoyama M, Kito S, Itoga E, Kishida T, Nanba K.
    Jpn J Pharmacol; 1982 Dec 03; 32(6):1157-66. PubMed ID: 6819376
    [Abstract] [Full Text] [Related]

  • 12. Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: effects of lesions.
    Murrin LC, Gale K, Kuhar MJ.
    Eur J Pharmacol; 1979 Dec 07; 60(2-3):229-35. PubMed ID: 43260
    [Abstract] [Full Text] [Related]

  • 13. Increase in D2 dopamine receptors in the substantia nigra after chronic (-)-sulpiride treatment.
    Stefanini E, Frau M, Gessa GL.
    Brain Res; 1991 Aug 02; 555(2):340-2. PubMed ID: 1834311
    [Abstract] [Full Text] [Related]

  • 14. Evidence that [3H]forskolin binding in the substantia nigra is intrinsic to a striatal-nigral projection: an autoradiographic study of rat brain.
    Gehlert DR, Dawson TM, Filloux FM, Sanna E, Hanbauer I, Wamsley JK.
    Neurosci Lett; 1987 Jan 14; 73(2):114-8. PubMed ID: 3822243
    [Abstract] [Full Text] [Related]

  • 15. Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats.
    Berger K, Przedborski S, Cadet JL.
    Brain Res Bull; 1991 Feb 14; 26(2):301-7. PubMed ID: 1826461
    [Abstract] [Full Text] [Related]

  • 16. Acute ethanol administration transiently decreases [3H]-DAMGO binding to mu opioid receptors in the rat substantia nigra pars reticulata but not in the caudate-putamen.
    Méndez M, Leriche M, Carlos Calva J.
    Neurosci Res; 2003 Oct 14; 47(2):153-60. PubMed ID: 14512140
    [Abstract] [Full Text] [Related]

  • 17. Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset.
    Gnanalingham KK, Milkowski NA, Smith LA, Hunter AJ, Jenner P, Marsden CD.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):235-41. PubMed ID: 7493614
    [Abstract] [Full Text] [Related]

  • 18. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC, Crossman AR, Woodruff GN.
    Brain Res; 1990 Apr 23; 514(1):93-102. PubMed ID: 2113410
    [Abstract] [Full Text] [Related]

  • 19. Injections of 6-hydroxydopamine in the substantia nigra of the rat brain: morphological and biochemical effects.
    Buonamici M, Cervini MA, Rossi AC, Sebastiani L, Raffaelli A, Bagnoli P.
    Behav Brain Res; 1990 Apr 16; 38(1):83-95. PubMed ID: 2112003
    [Abstract] [Full Text] [Related]

  • 20. Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine.
    MacKenzie RG, Stachowiak MK, Zigmond MJ.
    Eur J Pharmacol; 1989 Sep 01; 168(1):43-52. PubMed ID: 2511032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.